Restrictive lung diseases\ Flashcards
What are the two general restrictive lung diseases?
1) Chronic interstitial (infiltrative) diseases
2) Chest wall disorders (NM diseases, severe obesity, pleural disease)
What characterizes the chronic interstitial diseases?
1) All of them have inflammation and fibrosis of the interstitium
2) Some of the diseases have intra-alveolar components (occurs when the lumen of the alveoli is affected)
3) Many of those diseases are of an unknown etiology
What is the typical presentation of restrictive lung diseases?
1) Restrictive hypoventilation
2) Impaired diffusion
3) Dyspnea (CO2 isn’t accumulated)
4) Hypoxia
5) Cyanosis
6) When examining the patient at the end of inspiration you will hear a belt-like sound with crackles as the air hits the affected wall
7) No wheezing
What will you see in a chest radiograph in patients with restrictive lung disease?
1) Bilateral nodules
2) Irregular lines (fibrosis)
What are the complications of restrictive lung disease?
1) Secondary Pulmonary Hypertension
2) Right-side heart failure (cor pulmonale)
What is meant by the usual interstitial pneumonia (UIP)?
It is the abnormal epithelial repair at sites of chronic injury, increasing the fibroblastic proliferation, with fibroblastic foci, With no intra-alveolar pathology
- It increases the risk of lung cancer
What is the etiology of usual interstitial pneumonia?
- It is of unknown cause but,
1) It usually occurs in males that are older than 50 years old
2) Environmental factors like cigarette smoking, metal fumes, and wood dust, that cause recurrent alveolar damage are usually associated with it
3) Genetic factors like the loss of germline function due to the loss of telomeres, or genetic variations that lead to the increase in mucin (MUC5B)
4) Impaired immunity (AID, like rheumatic disease)
Describe the morphology of usual interstitial pneumonia
1) Gross:
- Pleura is “COBBLESTONE”
- Cut surface shows white area of fibrosis
2) Microscopic:
- Fibroblastic foci (heterogenous fibrosis):
1) Pathcy and myxoid areas (subpleural and para septal, this indicates that normal tissue is beside an abnormal one”)
2) Early and late fibrotic lesions are found at the same time (“TEMPORAL HETEROGENEITY”)
3) Areas of fibrosis are adjacent to normal-appearing lung parenchyma
- Patchy chronic inflammation
- Architectural distortion and (“HONEYCOMBING”) (the fibrosis will destroy the alveolar architecture, forming cysts lined by hyperplastic type-2 pneumocytes)
What is the treatment of the usual interstitial pneumonia?
- Anti-fibrotic therapy
1) Nintedanib
2) Pirfenidone (TGF-B inhibitor)
What is meant by non-specific interstitial pneumonia?
- It is the second most common type of interstitial pneumonia
- It is non-specific and thus there is a varying degree of fibrosis and inflammation that does not match the criteria of any of the well-characterized interstitial diseases with a better prognosis
- There is no intra-alveolar pathology
What is the morphology of the non-specific interstitial pneumonia?
- There is DIFFUSE & UNIFORMED Fibrosis (TEMPORAL HOMOGENEITY), due to chronic interstitial inflammation
What is meant by cryptogenic organizing pneumonia (Bronchiolitis obliterans organizing pneumonia)?
Cryptogenic “Unknown” Organizing “Healing” Pneumonia
- What happens is a factor (fumes, bacteria, viruses, etc.) has injured the alveolar & bronchiolar epithelium and during the repair, you’ll have a fibrous plug in the alveoli. This body comprises fibrous tissue + necrotic cells + inflammatory cells + fibroblasts+ collagen etc.
- Pneumonia is present here, with intra-alveolar component
- It is not specific for any etiological agent, seen in many settings, Inhalation of toxic materials, after administration of some drugs
- Cigarettes are not a predisposing factors
Describe the morphology of the cryptogenic organizing pneumonia
1) Radiology
- Atoll sign (characteristic for BOOP, wherein the CT you will find a black area surrounded by a white area “like an island”)
2) Microscopic
- Patchy
- Nodules of myxoid loose tissue with plasma cells, lymphocytes, and histiocytes (Masson bodies “APC”) filling the alveolar spaces and bronchioles “Bronchiolitis obliterans”
- Mild chronic interstitial inflammation with fibrosis
What is meant by acute respiratory distress syndrome (ARDS, “Acute Lung Injury ALI”, “Acute Interstitial Pneumonia AIP”, Diffused Alveolar Damage DAD”)?
Respiratory Failure within 1-week of a known clinical insult, with bilateral opacities on the chest imaging that are not fully explained by effusion, atelectasis, cardiac failure, or fluid overload
What is the cause of acute respiratory distress syndrome?
- Extensive bilateral injury to the alveoli:
1) Primary pulmonary disease (PNEUMONIA): COVID-19, Aspiration
2) Severe systemic inflammation: Trauma, Sepsis, Pancreatitis, transfusion reaction ( excessive immune response. The immune system will pour many cytokines that reach the lung, activating the endothelium of the pulmonary capillaries, and attracting neutrophils. It releases all the mediators in it damaging everything around it, The macrophages will come and try to clean up and induce fibrosis and this is why this syndrome although “acute” was grouped here due to it ultimately leading to fibrosis)
What is the pathogenesis of acute respiratory distress syndrome?
- Endothelial & epithelial injury
1) Endothelial activation
- Caused by pneumocyte injury or circulating inflammatory mediators, resulting in the binding of the neutrophils to the activated- end emigrating to the alveoli and interstitium releasing mediators, ROS, and proteases
2) Accumulation of intra-alveolar fluid and formation of HYALINE MEMBRANE (due to the protein-rich edema)
- Hyaline Membrane 🡪 pinkish appearance in which the membrane has no functional cells
- Endothelial activation and injury make the pulmonary capillaries leaky leading to interstitial and intra-alveolar edema (protein-rich edema, where fluid and debris accumulate), in addition to the damage of the type-2 pneumocytes which will decrease the amount of surfactant produced decreasing gas exchange
3) If inflammation persists
- Fibrosis will occur due to the removal of debris by the macrophages releasing fibrogenic cytokines (TGF-B, PDGF)
- Bronchial stem cell proliferation to replace the damaged pneumocytes
What is the clinical presentation of acute respiratory distress syndrome?
1) Abrupt onset of hypoxemia
2) Bilateral pulmonary edema (without cardiac failure)